Russian investment vehicle sets sights on innovative drugs
27 March 2013 Business
Rusnano hopes to make a killing by investing in new technologies in the pharmaceutical sector
The release from prison of Olga Zelenina, a chemist who was arrested on charges of aiding drug trafficking, on 25 September comes after an outcry by Russian scientists and human rights activists. Her supporters point out that she fell foul of contradictory drug laws and her arrest can be seen as an attempt to silence scientists who act as expert witnesses in court cases. Less than 24 hours after her release, there are reports that new charges have been brought against the chemist, accusing Zelenina of misleading a court over her level of expertise. The date of her trial has not yet been set.
Zelenina was arrested on 15 August at her home near the city of Penza. The Russian Federal Drug Control Service (FDCS) claimed that Zelenina was aiding Roman Shilov, a Moscow businessman who is accused of smuggling 42 tonnes of poppy seeds containing illegal drug impurities – opium, morphine, codeine and thebaine – through Russian customs.

The statue of Themis that stands outside Moscow's Supreme Court
Zyuzinsky District Court in Moscow rejected the petition of the investigating authorities to extend Zelenina’s detention and ruled that she be released pending her trial, which is likely to be in October. The court ruled that there were not sufficient grounds to hold her any longer as she is not at risk of jumping bail, engaging in criminal activities, pressuring witnesses or destroying evidence.
The actions of the FDCS have raised suspicions that the case was brought against Shilov to destroy him. At the same time, supporters of Zelenina believe that the case against her is a sham.
According to Natalia Andreeva, Zelenina’s lawyer, ‘this case is a very good way to get rid of Olga as a specialist in so-called poppy cases’. She noted that her client, an expert in poppy chemistry, provided authoritative reports in a number of criminal cases being investigated by the FDCS. And, this October, she was expected to be an expert witness in the trial of another businessman, Alexander Polukhin, who has also been charged with selling poppy seeds for drug purposes. Zelenina has criticised the conclusions of FDCS experts in Polukhin’s case, saying that they had made mistakes. Zelenina’s lawyers say that this has angered Russian law enforcement agencies.
On top of this, Andreeva says that some Russian law enforcement agency officials are unhappy with Zelenina’s advocacy on changes to the current guidelines for determining drug content in poppy seeds. She has said in the past that the technical standard, which requires poppy seeds be free of opioids should be changed as it cannot be met.
Meanwhile, Zelenina’s case has caused uproar in the Russian scientific community, with many well-known Russian scientists have already declared their support for the scientist, including Vladimir Lukin, Russia’s human rights commissioner.
‘There is an urgent need to improve Russian legislation in the field of drug control,’ says Irina Lewontina, a well-known Russian linguist and one of Zelenina’s supporters. ‘I know that it is written badly, giving huge scope for arbitrariness and corruption. As a scientist, I do not want to see criminal prosecutions for scientific opinions in our country. Being a linguist, I often speak in the courts, and I understand how dangerous it is to be arrested for [expressing my] professional judgment.’
27 March 2013 Business
Rusnano hopes to make a killing by investing in new technologies in the pharmaceutical sector
3 May 2012 News and Analysis
Simpler recognition process for foreign qualifications planned to attract more skilled workers
13 May 2013 Research
'Liquid fingerprinting' can 'taste' the difference between red wines, mineral waters and vodkas
15 May 2013 Research
The environmental legacy of salvaging gold from electronic waste can be dramatically cut using corn starch instead of cyanide
14 May 2013 News and Analysis
New legislation proposes the appointment of a public champion for research
7 May 2013 News and Analysis
While the EU is zeroing in on neonicotinoids as a major cause of bee deaths, the US is looking elsewhere